ETF Components for GNOM - Global X Genomics & Biotechnology ETF
Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.
Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.
Holdings
| Symbol | Grade | Price % Change | Allocation | |
|---|---|---|---|---|
| ALNY | C | 2.75 | 7.52 | |
| RNA | C | -0.92 | 6.04 | |
| NTRA | B | 2.65 | 4.88 | |
| BNTX | B | -1.43 | 4.77 | |
| RARE | D | 0.00 | 4.62 | |
| VCYT | A | 1.69 | 4.58 | |
| ILMN | A | 3.90 | 4.39 | |
| TECH | B | 2.12 | 4.11 | |
| SRPT | D | -2.15 | 4.01 | |
| QGEN | D | 2.33 | 3.80 | |
| LEGN | F | -1.47 | 3.76 | |
| A | D | 5.03 | 3.60 | |
| MYGN | F | -18.08 | 3.48 | |
| ARWR | F | 1.35 | 3.28 | |
| CRSP | C | 9.42 | 3.24 | |
| BMRN | F | 1.08 | 2.91 | |
| NTLA | F | 4.15 | 2.82 | |
| BEAM | F | 4.66 | 2.74 | |
| RCKT | F | 1.98 | 2.69 | |
| GILD | A | 0.78 | 2.52 | |
| VRTX | D | -1.02 | 2.25 | |
| TXG | F | 1.87 | 2.14 | |
| CDNA | D | 2.30 | 2.06 | |
| MRNA | F | 0.50 | 1.85 | |
| VIR | B | 23.63 | 1.25 | |
| PACB | C | 12.44 | 0.85 | |
| SANA | F | 4.57 | 0.84 | |
| RGNX | F | 2.33 | 0.77 | |
| FLGT | C | 0.75 | 0.72 | |
| VERV | C | 3.49 | 0.61 | |
| QURE | B | 2.45 | 0.52 | |
| ALLO | D | 6.46 | 0.48 | |
| EDIT | F | 0.34 | 0.48 | |
| TSVT | D | 1.38 | 0.43 | |
| PSTX | D | 4.22 | 0.33 | |
| CRBU | D | 12.76 | 0.26 | |
| LYEL | F | 16.63 | 0.20 | |
| BLUE | F | 0.43 | 0.17 | |
| SCLX | D | 1.16 | 0.01 |
Represented by ETF Holdings
Recent News for Global X Genomics & Biotechnology ETF & its Holdings
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index").
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
Exchange Traded Fund ETF Index Fund Biotechnology Genomics
Exchange Traded Fund ETF Index Fund Biotechnology Genomics
Popular Now
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles
